Skip to content

APOTHEEK MINERVA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK MINERVA

BE 0774.449.483
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€5,540
2024 · -€3,221-€2,319
Equity
€43,010
2024 · €48,550-€5,540
Cash
€19,268
2024 · €8,213+€11,055
Balance sheet total
€1.8m
2024 · €445,169+€1.4m

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€1.4m

    up €1.4m (+1,639%), from €84,057 to €1.5m

    of which Land and buildings: +€1.4m

  • Intangible fixed assets -€31,500

    down €31,500 (-17.8%), from €176,784 to €145,284

  • Receivables within one year +€20,865

    up €20,865 (+31.8%), from €65,554 to €86,419

    of which Trade receivables: +€21,194

Equity and liabilities
  • Debts after one year +€1.3m

    up €1.3m (+510%), from €258,527 to €1.6m

  • Current portion of long-term debt +€45,860

    up €45,860 (+107%), from €42,966 to €88,826

Income statement
  • Gross operating margin +€71,384

    up €71,384 (+37.1%), from €192,415 to €263,799

  • Financial charges +€22,477

    up €22,477 (+173%), from €12,999 to €35,475

  • Other operating charges +€22,062

    up €22,062 (+1,491%), from €1,479 to €23,541

  • Depreciation +€20,556

    up €20,556 (+46.5%), from €44,164 to €64,720

  • Staff costs +€8,461

    up €8,461 (+6.1%), from €137,740 to €146,201

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€3,221
Gross operating margin +€71,384
Staff costs -€8,461
Depreciation -€20,556
Other operating charges -€22,062
Financial income -€147
Financial charges -€22,477
Result 2025 -€5,540
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€57,542
Investment -€1.4m
Financing +€1.4m
Cash 2024 €8,213
Net result for the year -€5,540
Depreciation +€64,720
Stocks and contracts +€4,404
Receivables within one year -€20,865
Deferred charges and accrued income -€4,237
Trade debts +€13,324
Tax, wage and social debts +€6,117
Smaller working-capital items -€382
Investment in fixed assets (net) -€1.4m
Debts after one year +€1.3m
Current portion of long-term debt +€45,860
Cash 2025 €19,268
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €445,169 €1,823,380 +€1.4m +310%
Fixed assets 21/28 €260,841 €1,607,299 +€1.3m +516%
Intangible fixed assets 21 €176,784 €145,284 -€31,500 -17.8%
Tangible fixed assets 22/27 €84,057 €1,462,015 +€1.4m +1,639%
Land and buildings 22 €2,622 €1,360,203 +€1.4m +51,770%
Plant, machinery and equipment 23 €78,313 €66,829 -€11,484 -14.7%
Furniture and vehicles 24 €3,122 €34,983 +€31,861 +1,021%
Current assets 29/58 €184,329 €216,081 +€31,752 +17.2%
Stocks and contracts in progress 3 €104,187 €99,783 -€4,404 -4.2%
Stocks 30/36 €104,187 €99,783 -€4,404 -4.2%
Amounts receivable within one year 40/41 €65,554 €86,419 +€20,865 +31.8%
Trade receivables 40 €65,220 €86,414 +€21,194 +32.5%
Other amounts receivable 41 €334 €5 -€329 -98.4%
Cash at bank and in hand 54/58 €8,213 €19,268 +€11,055 +135%
Deferred charges and accrued income 490/1 €6,374 €10,611 +€4,237 +66.5%
Total equity and liabilities 10/49 €445,169 €1,823,380 +€1.4m +310%
Equity 10/15 €48,550 €43,010 -€5,540 -11.4%
Contributions 10/11 €50,000 €50,000 = 0.0%
Profit (loss) carried forward 14 -€1,450 -€6,990 -€5,540 -382%
Amounts payable 17/49 €396,619 €1,780,370 +€1.4m +349%
Amounts payable after more than one year 17 €258,527 €1,577,359 +€1.3m +510%
Financial debts 170/4 €258,527 €1,577,359 +€1.3m +510%
Amounts payable within one year 42/48 €134,169 €197,803 +€63,634 +47.4%
Current portion of amounts payable after more than one year 42 €42,966 €88,826 +€45,860 +107%
Trade debts 44 €38,304 €51,628 +€13,324 +34.8%
Suppliers 440/4 €38,304 €51,628 +€13,324 +34.8%
Taxes, remuneration and social security 45 €12,500 €18,616 +€6,117 +48.9%
Taxes 450/3 €1,218 €2,888 +€1,670 +137%
Remuneration and social security 454/9 €11,281 €15,728 +€4,447 +39.4%
Other amounts payable 47/48 €40,400 €38,732 -€1,667 -4.1%
Accrued charges and deferred income 492/3 €3,923 €5,208 +€1,285 +32.8%
Remuneration, social security and pensions 62 €137,740 €146,201 +€8,461 +6.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €44,164 €64,720 +€20,556 +46.5%
Other operating charges 640/8 €1,479 €23,541 +€22,062 +1,491%
Gross operating margin 9900 €192,415 €263,799 +€71,384 +37.1%
Operating profit (loss) 9901 €9,032 €29,337 +€20,305 +225%
Financial income 75/76B €746 €598 -€147 -19.8%
Recurring financial income 75 €746 €598 -€147 -19.8%
Financial charges 65/66B €12,999 €35,475 +€22,477 +173%
Recurring financial charges 65 €12,999 €35,475 +€22,477 +173%
Profit (loss) for the period before taxes 9903 -€3,221 -€5,540 -€2,319 -72.0%
Profit (loss) for the period 9904 -€3,221 -€5,540 -€2,319 -72.0%
Profit (loss) for the period to be appropriated 9905 -€3,221 -€5,540 -€2,319 -72.0%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.